The Beauty Health Company

NasdaqCM:SKIN Rapport sur les actions

Capitalisation boursière : US$187.3m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Beauty Health Gestion

Gestion contrôle des critères 1/4

Le PDG Beauty Health's est Marla Beck, nommé en Nov2023, a un mandat de moins d'un an. La rémunération annuelle totale est $ 2.31M, composée du salaire de 8% et des bonus 92%, y compris les actions et options de la société. détient directement 0.057% des actions de la société, d'une valeur de $ 103.22K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.6 ans et 3.3 ans.

Informations clés

Marla Beck

Directeur général

US$2.3m

Rémunération totale

Pourcentage du salaire du PDG8.0%
Durée du mandat du directeur généralless than a year
Propriété du PDG0.06%
Durée moyenne d'occupation des postes de direction1.6yrs
Durée moyenne du mandat des membres du conseil d'administration3.3yrs

Mises à jour récentes de la gestion

Recent updates

Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Aug 06
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Jul 16
Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Jun 14
Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

May 30
Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

Feb 16
The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Jun 19
The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

May 28
Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Apr 04
At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

Mar 08
Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

Jan 01
What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

Oct 12

Beauty-Health Company announces $200M buyback program

Sep 27

The Beauty Health Q2 2022 Earnings Preview

Aug 08

The Beauty Health Company: Not Looking The Best

Jul 30

Beauty Health: Skincare Today And Alpha Tomorrow

May 13

Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Apr 22
Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Analyse de la rémunération des PDG

Comment la rémunération de Marla Beck a-t-elle évolué par rapport aux bénéfices de Beauty Health?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$84m

Mar 31 2024n/an/a

-US$81m

Dec 31 2023US$2mUS$185k

-US$100m

Sep 30 2023n/an/a

-US$84m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$175kn/a

US$44m

Rémunération vs marché: La rémunération totale de Marla ($USD 2.31M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 1.52M ).

Rémunération et revenus: La rémunération de Marla a augmenté alors que l'entreprise n'est pas rentable.


PDG

Marla Beck (54 yo)

less than a year

Titularisation

US$2,308,461

Compensation

Ms. Marla Malcolm Beck serves as Member of Board of Advisors of Glowbar, Inc. since January 2023. She is Director at GLO Pharma, Inc. since September 7, 2022. She was an Independent Director of The Beauty...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Marla Beck
Presidentless than a yearUS$2.31m0.057%
$ 106.0k
Michael Monahan
Chief Financial Officerless than a yearUS$3.26m0.073%
$ 136.5k
Daniel Watson
Chief Revenue Officer1.6yrsUS$3.01m0.23%
$ 437.2k
Sheri Lewis
Chief Supply Chain & Operations Officerless than a yearpas de donnéespas de données
Paul Bokota
VP & General Counsel3.8yrspas de donnéespas de données
Celeste Ortiz
Chief Human Resources Officer1.6yrspas de donnéespas de données
Mingo Ku
President of APAC3yrspas de donnéespas de données
Jon Arnold
President of EMEA2yrspas de donnéespas de données

1.6yrs

Durée moyenne de l'emploi

56yo

Âge moyen

Gestion expérimentée: L'équipe de direction de SKIN n'est pas considérée comme expérimentée (ancienneté moyenne 1.6 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Marla Beck
President2.2yrsUS$2.31m0.057%
$ 106.0k
Brian Miller
Independent Director3.3yrsUS$207.49k0.074%
$ 138.1k
Michael Capellas
Independent Director3.3yrsUS$214.99k0.16%
$ 298.4k
Douglas Schillinger
Independent Director3.3yrsUS$219.99k0.052%
$ 97.3k
Brenton L. Saunders
Chairman3.3yrsUS$353.24k6.93%
$ 13.0m
Desiree Gruber
Independent Director3.2yrsUS$202.49k0.045%
$ 84.0k
Michelle Kerrick
Independent Director3.3yrsUS$219.99k0.031%
$ 57.7k
Julius Few
Independent Director3.3yrsUS$199.99k0.093%
$ 174.9k

3.3yrs

Durée moyenne de l'emploi

56yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de SKIN sont considérés comme expérimentés (ancienneté moyenne 3.3 ans).